Search Count: 18
 |
Phosphoheptose Isomerase Gmha From Burkholderia Pseudomallei Bound To Inhibitor Mut148233
Organism: Burkholderia pseudomallei 1106a
Method: X-RAY DIFFRACTION Resolution:1.31 Å Release Date: 2023-12-13 Classification: ISOMERASE/INHIBITOR Ligands: J7D, ZN, CL, NA |
Organism: Burkholderia pseudomallei 1106a
Method: X-RAY DIFFRACTION
Release Date: 2023-12-13
Ligands: J7D, ZN, CL, NA
 |
Phosphoheptose Isomerase Gmha From Burkholderia Pseudomallei Bound To Inhibitor Mut148591
Organism: Burkholderia pseudomallei 1106a
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2023-12-06 Classification: ISOMERASE/INHIBITOR Ligands: XLR, ZN, CL, NA |
Organism: Burkholderia pseudomallei 1106a
Method: X-RAY DIFFRACTION
Release Date: 2023-12-06
Ligands: XLR, ZN, CL, NA
 |
Biological And Structural Analysis Of New Potent Integrase-Ledgf Allosteric Hiv-1 Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: RWR, MG, SO4 Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: RWR, MG, SO4
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Bdm-2
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: RWR, EDO, CL, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: RWR, EDO, CL, MG
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut871
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: EDO, CL, U5L, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: EDO, CL, U5L, MG
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut872
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: W2Q, EDO, MG, PEG, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: W2Q, EDO, MG, PEG, CL
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut884
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: CL, EDO, U60, MG, PGE |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: CL, EDO, U60, MG, PGE
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut916
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: EDO, PEG, U5S, MG, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: EDO, PEG, U5S, MG, CL
 |
Structural Basis For The Inhibition Of E. Coli Pbp2
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2019-05-22 Classification: HYDROLASE/ANTIBIOTIC Ligands: NXL |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2019-05-22
Ligands: NXL
 |
Structural Basis For The Inhibition Of E. Coli Pbp2
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-05-22 Classification: HYDROLASE/ANTIBIOTIC |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2019-05-22
 |
Structural Basis For The Inhibition Of E. Coli Pbp2
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-05-22 Classification: HYDROLASE/ANTIBIOTIC Ligands: ET5 |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION
Release Date: 2019-05-22
Ligands: ET5
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VN, SO4 Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VN, SO4
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: 9VK, MG Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: 9VK, MG
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VN, SO4 Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VN, SO4
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VK, SO4 Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VK, SO4
 |
Dual Inhibition Of Hiv-1 Replication By Integrase-Ledgf Allosteric Inhibitors Is Predominant At Post-Integration Stage During Virus Production Rather Than At Integration
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-12-25 Classification: TRANSFERASE Ligands: MG Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-12-25
Ligands: MG
 |
Dual Inhibition Of Hiv-1 Replication By Integrase-Ledgf Allosteric Inhibitors Is Predominant At Post-Integration Stage During Virus Production Rather Than At Integration
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2013-12-25 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: LF0, MG Modified Residue(s): CAS |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-12-25
Ligands: LF0, MG